Increased Expression of Clusterin in Kidney of a Fatal Nephropathia Epidemica Case

被引:0
作者
Anohin V.A. [1 ]
Martynova E.V. [2 ]
Martynov V.A. [3 ]
Masgutova G.A. [2 ]
Rizvanov A.A. [2 ]
Khaiboullina S.F. [2 ,4 ]
机构
[1] Kazan State Medical University, Kazan, Republic of Tatarstan
[2] Kazan Federal University, Kazan, Republic of Tatarstan
[3] Department of Infectious Diseases, Ryazan State Medical University, Ryazan
[4] University of Nevada, Reno, NV
基金
俄罗斯科学基金会;
关键词
Clusterin; Hemorragic fever with renal syndrome; Kidney autopsy sample; Nephropathia epidemica;
D O I
10.1007/s12668-016-0244-7
中图分类号
R318.08 [生物材料学]; Q [生物科学];
学科分类号
07 ; 0710 ; 0805 ; 080501 ; 080502 ; 09 ;
摘要
Nephropathia epidemica (NE), a mild form of hemorrhagic fever with renal syndrome (HFRS), is endemic in the European part of Russia. This disease is characterized by an acute onset followed by symptoms related to kidney impairment. Histologically, NE is defined as a tubulointerstitial nephritis with the prominent leukocyte infiltration and interstitial hemorrhages. Also, the presence of IgM, complement component C3, and fibrin deposits along the basal surface of the tubular epithelial cells has been reported. The pathogenesis of immunoglobulin and complement deposition in the kidney tubules remains unknown. We found clusterin deposits in the kidney tissue from fatal NE. Clusterin was co-localized with hantavirus antigens and C3 complement on the basal side of the kidney tubules. Additionally, kidney infiltrating leukocytes were positive for clusterin. It has previously been documented that the expression of clusterin is restricted to epithelial cells and is often found on tubular cells of the injured kidney tissue. Additionally, clusterin can bind to immunoglobulins and complement components. We propose that upregulation of clusterin expression in the NE kidney is associated with damage to the tissue and may cause deposition of immunoglobulins and complement. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:453 / 456
页数:3
相关论文
共 24 条
[1]  
Khismatullina N.A., Et al., Epidemiological dynamics of nephropathia epidemica in the Republic of Tatarstan, Russia, during the period of 1997-2013, Epidemiology and Infection, 144, 3, pp. 618-626, (2016)
[2]  
Muranyi W., Et al., Hantavirus infection, Journal of the American Society of Nephrology, 16, 12, pp. 3669-3679, (2005)
[3]  
Mustonen J., Et al., Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica, Clinical Nephrology, 41, 3, pp. 121-126, (1994)
[4]  
Groen J., Et al., Hantavirus antigen detection in kidney biopsies from patients with nephropathia epidemica, Clinical Nephrology, 46, 6, pp. 379-383, (1996)
[5]  
Ferluga D., Vizjak A., Hantavirus nephropathy, Journal of the American Society of Nephrology, 19, 9, pp. 1653-1658, (2008)
[6]  
Sane J., Et al., Complement activation in Puumala hantavirus infection correlates with disease severity, Annals of Medicine, 44, 5, pp. 468-475, (2012)
[7]  
Terajima M., Et al., Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica, Microbes and Infection, 6, 2, pp. 238-245, (2004)
[8]  
Paakkala A., Et al., Complement activation in nephropathia epidemica caused by Puumala hantavirus, Clinical Nephrology, 53, 6, pp. 424-431, (2000)
[9]  
Papadimitriou M., Hantavirus nephropathy, Kidney International, 48, 3, pp. 887-902, (1995)
[10]  
Temonen M., Et al., Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study, Clinical Immunology and Immunopathology, 78, 1, pp. 47-55, (1996)